3-Amino-4-methoxybenzanilide

We are 3-Amino-4-methoxybenzanilide CAS:120-35-4 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name: 3-Amino-4-methoxybenzanilide
CAS.NO:120-35-4
Synonyms:3-Amino-p-anisanilide;3-Amino-4-Methoxybenzanilide;3-amino-4-methoxy-N-phenylbenzamide
Molecular Formula:C14H14N2O2
Molecular Weight:242.27300
 
Physical and Chemical Properties:
Density:1.245g/cm3
Boiling point:364.5ºC at 760mmHg
Melting point:154-156°C
Flash point:174.3ºC
Index of Refraction:1.658
 
Specification:
Appearance:White  powder
Purity:≥99.0%
 
Packing: 25kg drum
Storage:Store in a tightly closed container. Store in a cool, dry, well-ventilated area away from incompatible substances. Flammables-area.
Application:Mainly used in the manufacture of organic pigments.
 

3-Amino-4-methoxybenzanilide


Related News: The Company’s immuno-regulatory product candidates include ProTmune, a pharmacologically modulated, donor cell graft that is currently being evaluated in a Phase 2 clinical trial for the prevention of graft-versus-host disease, and a myeloid-derived suppressor cell immunotherapy for promoting immune tolerance in patients with immune disorders. Fate Therapeutics is headquartered in San Diego, CA.4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine CAS:106006-83-1 “Inceptua Medicines Access is delighted to be selected as Onconova’s partner for the Pre-approval Access Program for rigosertib.4-(Trifluoromethoxy)benzyl alcohol CAS:1736-74-9 “Inceptua Medicines Access is delighted to be selected as Onconova’s partner for the Pre-approval Access Program for rigosertib.ethyl 5-(ethoxycarbonylsulfamoyl)-1-methylpyrazole-4-carboxylate CAS:159709-60-1 In the context of increasingly tight global productive capacity cooperation in the pharmaceutical industry, some multinational pharmaceutical companies have chosen to abandon their original full industrial chain model and shift their focus to market operations. R & D, clinical, and production links reduce costs through outsourcing. Patented APIs came into being.In the context of increasingly tight global productive capacity cooperation in the pharmaceutical industry, some multinational pharmaceutical companies have chosen to abandon their original full industrial chain model and shift their focus to market operations. R & D, clinical, and production links reduce costs through outsourcing. Patented APIs came into being.

Related Products
Product Name
2-Ethoxy-3-methylpyrazine View Details
3-Chloro-5-fluorobenzoic acid View Details
3-Bromo-4-fluorotoluene View Details
1-Chloro-3-fluoro-2-(trifluoromethyl)benzene manufacturer Butyl methanesulfonate manufacturer Methyl 4-amino-5-(ethylsulfonyl)-2-methoxybenzoate manufacturer 4-amino-2,3-dihydroisoindol-1-one manufacturer spiro[1-azabicyclo[2.2.2]octane-3,2′-oxirane],hydrochloride manufacturer